Citation only
via OpenAlex
NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis
Experimental Gerontology · 2020 · ▲ 92 citations
Abstract
This 2020 article in Experimental Gerontology examines the potential benefits and risks associated with NAD+ therapy for age-related degenerative disorders.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.exger.2020.110831
- Canonical
- link ↗
- Fetched
- 2026-09-15 MST
Cite this
APA
Braidy, N., & Liu, Y. (2020). NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis. <em>Experimental Gerontology</em>. https://doi.org/10.1016/j.exger.2020.110831
Vancouver
Braidy N, Liu Y. NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis. Experimental Gerontology. 2020. doi:10.1016/j.exger.2020.110831.
BibTeX
@article{nady2020NADthe,
title = {NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis},
author = {Nady Braidy and Yue Liu},
journal = {Experimental Gerontology},
year = {2020},
doi = {10.1016/j.exger.2020.110831},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Biochemical and Biophysical Research Communications 2010
Citation only
Genomic analysis of the telomeric length effect on organismic lifespan in Caenorhabditis elegans
Journal of Affective Disorders 2025
Citation only
Sleep disorders and aging: Mendelian randomization analysis of epigenetic and frailty markers
Mechanisms of Ageing and Development 2024
Citation only
A mechanistic analysis of metformin's biphasic effects on lifespan and healthspan in C. elegans: Elixir in youth, poison in elder
Clinica Chimica Acta 2026
Citation only
Biochemical markers of metabolic disorders: an age-specific approach to reducing type 2 diabetes and cardiovascular disease risk
Zenodo (CERN European Organization for Nuclear Research) 2025
Preprint · CC-BY
BIOCHEMICAL MARKERS OF METABOLIC DISORDERS: AN AGE-SPECIFIC APPROACH TO REDUCING TYPE 2 DIABETES AND CARDIOVASCULAR DISEASE RISK
Trends in Molecular Medicine 2017
Preprint · CC-BY